Table 2.
Number of survivors (%) | |
---|---|
Arthralgias (symptom onset during ETU or after discharge) | 210 (76%) |
Any auditory symptoms (tinnitus, aural fullness, hearing loss) that started during ETU or after discharge | 67 (24%) |
Ocular symptoms (onset during ETU or after discharge) | 167 (60%) |
Blurry vision | 104 (38%) |
Light sensitivity | 86 (31%) |
Itchy eye | 86 (31%) |
Tearing | 79 (29%) |
Pain | 72 (26%) |
Foreign body sensation | 68 (25%) |
Floaters | 46 (17%) |
Redness | 46 (17%) |
Flashes of light | 43 (16%) |
Dry eye | 39 (14%) |
Burning sensation | 29 (11%) |
Loss of vision | 7 (3%) |
Uveitis diagnosed on slit-lamp and dilated fundoscopic examination* (68 eyes involved among 50 patients) | 50 (18%) |
Anterior uveitis | 31 (46%) |
Posterior uveitis | 18 (26%) |
Intermediate uveitis | 2 (3%) |
Panuveitis | 17 (25%) |
ETU = Ebola treatment unit.
A patient could have >1 type of uveitis if both eyes were involved.